The effect of aliskiren on platelet activity is not clear. In an in vitro study biomarkers of platelet activity were not altered by aliskiren (except for a moderate increase of antithrombin-III activity). At higher doses (exceeding its therapeutic range) it had a diverging effect - both platelet activating and antiplatelet effects